MRI microscopy of mouse and human pancreas with respective histology, demonstrating the ability of DTI maps (Fractional anisotropy and Axial diffusivity) to identify pre-malignant lesions (black ...

Pancreatic metastases are rare and frequently misdiagnosed, leaving clinicians uncertain about how to assess prognosis and select optimal treatment. In a recent large single-center retrospective study ...

Titled "Stereotactic MRI-Guided On-table Adaptive Radiation Therapy (SMART) for Locally Advanced Pancreatic Cancer," this study was the first Phase II prospective international multi-institutional ...

National Taiwan University Hospital has recently launched a new AI-powered diagnostic imaging service for pancreatic cancer. Offered as a self-pay service at the NTUH Department of Medical Imaging ...

A mechanistic radiographic and biologic phase II single-agent study of sunitinib in relapsed/refractory esophageal (E) and gastroesophageal (GE) cancers. Background: SUVs of FDG-PET are ...

Surufatinib combined with TAS-102 in third- or later-line therapy of patients with metastatic pancreatic cancer (mPDAC): An open-label, single-arm, phase II study.

Pancreatic cancer remains one of the most challenging cancers to detect early, contributing to its reputation as a silent disease with poor survival rates. The pancreas—a leaf-shaped organ tucked ...

When pancreatic cancer spreads to other areas of the body, a person may experience new symptoms that are not directly linked to the tumors in the pancreas. In the later stages, pancreatic cancer ...

Dr. Anju Goel, MD, MPH, is a public health consultant and physician with more than 10 years of experience in the California public health system. The pancreas is an organ that makes enzymes for ...